Skip to main content
Timothy Ley, MD, Hematology, Saint Louis, MO

TimothyJLeyMD

Hematology Saint Louis, MO

Hematologic Oncology, Sickle Cell & Other Anemias

Professor of Medicine

Dr. Ley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ley's full profile

Already have an account?

  • Office

    1 Barnes Jewish Hospital Plz
    # Div
    Saint Louis, MO 63110
    Phone+1 314-362-8831
    Fax+1 314-362-9333

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1983 - 1984
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1980 - 1983
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1980
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1978 - 1979
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1978, MD
  • Drake University
    Drake UniversityBA, Biology, 1971 - 1974

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1986 - 2025
  • MD State Medical License
    MD State Medical License 1981 - 1986
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Elected National Academy of Sciences, 2019
  • Elected American Academy of Arts and Sciences, 2010
  • Elected National Academy of Medicine, 2003
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Differences in human ?, ?, and ?-globin gene expression in monkey kidney cells.  
    Humphries, R.K., Ley, T.J., Turner, P., Moulton, A.D., and Nienhuis, A.W, Cell 30:173-183
  • RNA processing errors in patients with ? thalassemia.  
    Ley, T.J., Anagnou, N., Pepe, G., and Nienhuis, and A.W, Proc. Natl. Acad. Sci. USA 79:4775-4779
  • Spontaneous subarachnoid hemorrhage simulating acute transmural myocardial infarction.  
    Gascon, P., Ley, T., Toltzis, R., and Bonow, R, Am. Heart J. 105:511-513
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The Molecular Basis of Long First Remissions in Normal Karyotype AML Patients
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Whole Genome Bisulfite Sequencing of 63 Primary AML Samples Identifies a Unique DNA Hypermethylation Signature for Mutant IDH1/2 Cases That Is Different from That of T...
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Gata2 Expression and Function in PML-RARA-driven Preleukemia and APL
    Timothy J Ley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Evidence for Complete Mutation Clearance in Normal Karyotype AML Patients with Very Long (> 5 years) Remissions after Chemotherapy Alone 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Basic Science Symposium on AML Genomics. 
    American Society of Hematology
  • Join now to see all

Press Mentions

  • Serendipity Unites Physicians, Researchers, Families to Fight Rare Genetic Disease in Kids
    Serendipity Unites Physicians, Researchers, Families to Fight Rare Genetic Disease in KidsMarch 24th, 2022
  • $5 Million Grant Endows Research to Advance Blood Disorder Therapies
    $5 Million Grant Endows Research to Advance Blood Disorder TherapiesSeptember 11th, 2019
  • $15 Million Supports Quest for Personalized Leukemia Therapies
    $15 Million Supports Quest for Personalized Leukemia TherapiesAugust 21st, 2019
  • Join now to see all

Grant Support

  • Genomics Of Acute Myelogenous Leukemia (Aml): Somatic Mutations &ConsequencesNational Cancer Institute2008–2012
  • AdministrationNational Cancer Institute2008–2012
  • The Biology Of Promyelocytic Leukemia In A Mouse ModelNational Cancer Institute2005–2012
  • Genomics Of Acute Myelogenous LeukemiaNational Cancer Institute2003–2012
  • Dmnt3a Mutations In Patients With Acute Myeloid LeukemiaNational Center For Research Resources2011
  • DNMT3A Mutations In Acute Myeloid LeukemiaNational Cancer Institute2011
  • Embryonic Stem Cell CoreNational Cancer Institute2010–2011
  • Regulation Of Fetal And Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Genomics Of AML: Whole Genome ResequencingNational Cancer Institute2010
  • Genomics Of Acute Myelogenous Leukemia (2po1ca101937-06)National Cancer Institute2010
  • Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Center For Research Resources2008–2010
  • Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
  • Regulation Of Fetal And Adult Human Hemoglobin ProdNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
  • Core--Embryonic Stem Cell FacilityNational Cancer Institute2004–2008
  • Hematopoietic Development And Malignancy ProgramNational Cancer Institute2004
  • The Role Of Granzymes In Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
  • The Biology Of Promyelocytic Leukemia In A Mouse MODEL.National Cancer Institute2000–2004
  • Regulation Of Fetal And Adult Human Hemoglobin ProductiNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2003
  • Stem Cell BiologyNational Cancer Institute2001–2002
  • Core--Embryonic Stem CellNational Cancer Institute2001–2002
  • Fetal And Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
  • Gene Regulation In Normal And Transformed CellsNational Cancer Institute1999
  • Regulation Of Human Cathepsin G Gene In Normal And Leukemic Blood CellsNational Cancer Institute1997–1999
  • Core--Embryonic Stem CellsNational Cancer Institute1997–1999
  • Granzymes And Cytotoxic Lymphocyte FunctionsNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
  • Regulation Of HemoglobinNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
  • Regulation Of HemoglobinNational Institute Of Diabetes And Digestive And Kidney Diseases1996
  • Regulation Of Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1995
  • Regulation Of Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Regulation Of Fetal &Adult Human Hemoglobin ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993